Unknown

Dataset Information

0

COVID-19 and risks to the supply and quality of tests, drugs, and vaccines.

ABSTRACT:

SUBMITTER: Newton PN 

PROVIDER: S-EPMC7158941 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

COVID-19 and risks to the supply and quality of tests, drugs, and vaccines.

Newton Paul N PN   Bond Katherine C KC  

The Lancet. Global health 20200409 6

Similar Datasets

Unknown Basophil activation tests with cryopreserved mRNA-based COVID-19 vaccines.
| S-EPMC10060195 | biostudies-literature
Unknown Recent Advances on Drugs and Vaccines for COVID-19.
| S-EPMC8673875 | biostudies-literature
Unknown Comparative Benefits and Risks Associated with Currently Authorized COVID-19 Vaccines.
| S-EPMC9788423 | biostudies-literature
Unknown Mucosal COVID-19 vaccines: Risks, benefits and control of the pandemic.
| S-EPMC9523321 | biostudies-literature
Unknown COVID-19: A game of drugs, vaccines, hope and… death!
| S-EPMC8253001 | biostudies-literature
Unknown COVID-19 Vaccines and Public Anxiety: Antibody Tests May Be Widely Accepted.
| S-EPMC9120666 | biostudies-literature
Unknown A spatial and dynamic solution for allocation of COVID-19 vaccines when supply is limited.
| S-EPMC9053274 | biostudies-literature
Unknown There Is No Evidence That Inactivated COVID-19 Vaccines Increase Risks of Uveitis Flare.
| S-EPMC9612251 | biostudies-literature
Unknown Vaccines and drugs under clinical trials for prevention and treatment of COVID-19.
| S-EPMC7984501 | biostudies-literature
Unknown Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines.
| S-EPMC9233673 | biostudies-literature